Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

Abstract

Lung cancer remains the leading cause of cancer‐related mortality worldwide. Despite advances in treatment, postoperative recurrence rates in early‐stage and locally advanced non‐small cell lung cancer (NSCLC) remain substantial. Prognostic models may support risk stratification and guide posttreatment management.